Advances in microbubble technology

Coronary Artery Disease

Volumn 11, Issue 3, 2000, Pages 211-219

  Skyba, Danny M ^a   Kaul, Sanjiv ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA MEDICAL CENTER   (United States)

Author keywords

Contrast agent; Microbubbles; Myocardial contrast echocardiography; Ultrasound

Indexed keywords

ALBUNEX; CONTRAST MEDIUM; ECHO CONTRAST MEDIUM; FS 069; PERFLUOROOCTYL BROMIDE; PERFLUOROPENTANE; PERFLUTREN; QUANTISON; SONOVUE; SONOZOID; UNCLASSIFIED DRUG;

CONTRAST ECHOCARDIOGRAPHY; CORONARY ARTERY DISEASE; HEART MUSCLE PERFUSION; HUMAN; PRIORITY JOURNAL; REVIEW;

CONTRAST MEDIA; CORONARY CIRCULATION; ECHOCARDIOGRAPHY; GASES; HUMANS; MYOCARDIAL ISCHEMIA;

EID: 0034113437     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200005000-00003     Document Type: Review

References (50)

1. 1 Kaul S. Myocardial perfusion and other applications of contrast echocardiography. In Braunwald E (editor): Heart disease: a textbook of cardiovascular medicine. Philadelphia: WB Saunders; 1997. pp. 481-503. An excellent overview of the potential clinical use of MCE in acute myocardial infarction, for the early detection of coronary artery disease, and for viability assessment in chronic coronary artery disease.
2. 2 deJong N. Basic principles of ultrasound contrast agents. In: Acoustic properties of ultrasound contrast agents. Woerden, The Netherlands: Zuidam and Zonen; 1993. pp. 17-36.
3. 3 Tei C, Sakamaki T, Shah PM, Meerbaum S, Shimoura K, Kondo S, et al. Myocardial contrast echocardiography: a reproducible technique of myocardial opacification for identifying regional perfusion defects [abstract]. Circulation 1983; 67:585.
4. 4 Forfar JC, Godman MJ. Functional and anatomical correlates in atrial septal defect. An echocardiographic analysis. Br Heart J 1985; 54:193-200.
5. 5 Goldman ME, Mindich BP. Intraoperative two - dimensional echocardiography: new application of an old technique. J Am Coll Cardiol 1986; 7:374-382.
6. 6 Kemper A, O'Boyle JE, Sharma S, Cohen CA, Kloner RA, Khuri SF, et al. Hydrogen peroxide contrast-enhanced two-dimensional echocardiography: real-time in vivo delineation of regional myocardial perfusion. Circulation 1983; 68:603-611.
7. 7 Feinstein SB, Ten Cate F, Zwehl W, Ong K, Maurer G, Tei C, et al. Two-dimensional contrast echocardiography, I: In vitro development and quantitative analysis of echo contrast agents. J Am Coll Cardiol 1984; 3:14-20.
8. 8 Moore CA, Smucker ML, Kaul S. Myocardial contrast echocardiography in humans: I. Safety - a comparison with routine coronary arteriography. J Am Coll Cardiol 1986; 8:1066-1072.
9. 9 Gillam LD, Kaul S, Fallon JT, Levine RA, Hedley-Whyte ET, Guerrero JL, et al. Functional and pathologic effects of multiple echocardiographic contrast injections on the myocardium, brain, and kidney. J Am Coll Cardiol 1985; 6:687-694.
10. 10 Lang RM, Borow KM, Neumann A, Feinstein SB. Echocardiographic contrast agents: effect of microbubbles and carrier solutions on left ventricular contractility. J Am Coll Cardiol 1987; 9:910-919.
11. 11 Keller MW, Glasheen WP, Teja K, Gear A, Kaul S. Myocardial contrast echocardiography without significant hemodynamic effects or reactive hyperemia: a major advantage in the imaging of myocardial perfusion. J Am Coll Cardiol 1988; 12:1039-1047.
12. 12 Reisner SA, Ong LS, Lichtenberg GS, Amico AF, Shapiro JR, Allen MN, et al. Myocardial perfusion imaging by contrast echocardiography with use of intracoronary sonicated albumin in humans. J Am Coll Cardiol 1989; 14:660-665.
13. 13 Christiansen C, Kryvi H, Sontum PC, Skotland T. Physical and biochemical characterization of Albunex, a new ultrasound contrast agent consisting of air-filled albumin microspheres suspended in a solution of human albumin [abstract]. Biotechnol Appl Biochem 1994; 19:307.
14. 14 Keller MW, Segal SS, Kaul S, Duling B. The behavior of sonicated albumin microbubbles within the microcirculation: a basis for their use during myocardial contrast echocardiography. Circ Res 1989, 65:458-467. This paper describes in detail the characteristics of sonicated albumin microbubbles within the microcirculation, and its relation to that of red blood cell rheology, including distribution, velocity, transit time and branch point flux.
15. 15 Christiansen C, Vebner AJ, Muan B, Vik H, Haider T, Nicolaysen H, et al. Lack of an immune response to Albunex, a new ultrasound contrast agent based on air-filled albumin microspheres [abstract]. Int Arch Allergy Immunol 1994; 104:372.
16. 16 Walday P, Tolleshaug H, Gjoen T, Kindberg GM, Berg T, Skotland T, et al. Biodistributions of air-filled albumin microspheres in rats and pigs. Biochem J 1994; 299:437-443.
17. 17 Hoff L, Christiansen C, Skotland T. Consideration about the contribution to acoustic backscatter from Albunex microspheres with different sizes [abstract]. J Ultrasound Med 1994; 43:481.
18. 18 Marcus ML. Metabolic regulation of coronary blood flow. In: The coronary circulation in health and disease. New York: McGraw Hill; 1983. pp. 65-92.
19. 19 Shapiro JR, Reisner SA, Lichtenberg GS, Meltzer RS. Intravenous contrast echocardiography with use of sonicated albumin in humans: systolic disappearance of left ventricular contrast after transpulmonary transmission. J Am Coll Cardiol 1990; 16:1603-1607.
20. 20 Vuille C, Nidorf M, Morrissey RL, Newell JB, Weyman AE, Picard MH. Effect of static pressure on the disappearance of specific echocardiographic contrast agents. J Am Soc Echocardiogr 1994; 7:347-353.
21. 21 Wei K, Kaul S. Recent advances in myocardial contrast echocardiography. Curr Opin Cardiol 1997; 12:539-546.
22. 22 Gholam A, Peyman, Joel A. Schulman?. Intraocular gases. In: Vitreous substitutes. East Norwalk, Connecticut: Appleton and Lange; 1995. pp. 61-67.
23. 23 Schneider M, Arditi M, Barrau M, Brochot J, Broillet A, Ventrone R, et al. BR1 : a new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles. Invest Radiol 1995; 30:451-457.
24. 24 Unger EC, Barrette TR: MRX-115: perfluoropropane gas filled lipid bilayers in an ultrastable US perfusion contrast agent. Radiology 1994; 193 (suppl):336.
25. 25 Skyba DM, Camarano G, Goodman NC, Price RJ, Skalak TC, Kaul S. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second generation contrast agent capable of producing myocardial opacification from a venous injection. J Am Coll Cardiol 1996; 28:1292-1300. This paper discusses the hemodynamic characteristics of a second generation contrast agent and explains the disparate myocardial kinetics of intracoronary versus intravenous injections of these agents. The safety of the second generation agent is also discussed.
26. 26 Lindner JR, Firschke C, Wei K, Goodman NC, Skyba DM, Kaul S. Myocardial perfusion characteristics and hemodynamic profile of MRX-115, a venous echocardiographic contrast agent, during acute myocardial infarction. J Am Soc Echocardiogr 1998; 11:36-46.
27. 27 Wei K, Firoozan S, Ates G, Linka A, Goodman NC, Kaul S. Quantification of the severity of coronary stenoses using venous injections of minute amounts of AFO150 during intermittent harmonic imaging [abstract]. J Am Coll Cardiol 1997, 29:292A.
28. 28 Grayburn PA, Erickson JM, Escobar J, Womack L, Velasco CE. Peripheral intravenous myocardial contrast echocardiography using a 2% dodecafluoropentane emulsion: identification of myocardial risk area and infarct size in the canine model of ischemia. J Am Coll Cardiol 1995; 26:1340-1347.
29. 29 Cotter B, Kwan OL, Cha YM, Dittrich H, et al. Dose response characteristics, time-course, and hemodynamic responses to QW3600, an ultrasound contrast agent capable of myocardial opacification by intravenous injection [abstract]. J Am Coll Cardiol 1994; 23:393A.
30. 30 Linka A, Ates G, Wei K, Firoozan S, Skyba DM, Kaul S. Three-dimensional myocardial contrast echocardiography: validation of in-vivo risk and infarct volumes. J Am Coll Cardiol 1997; 30:1892-1899.
31. 31 Firschke C, Lindner JR, Wei K, Goodman NC, Skyba DM, Kaul S. Myocardial perfusion imaging in the setting of coronary artery stenosis and acute myocardial infarction using venous injection of a second generation echocardiographic contrast agent. Circulation 1997; 96:959-967. This study demonstrates the use of intravenous injections of a second generation agent during intermittent harmonic imaging to quantify the severity of stenoses, as well as to determine and locate risk areas and infarct sizes.
32. 32 Schrope B, Newhouse VL, Uhlendorf V. Simulated capillary flow measurement using a nonlinear ultrasonic contrast. Ultrasonic Imaging 1992; 14:134-158.
33. 33 Schrope BA, Newhouse VL. Second harmonic ultrasonic blood perfusion measurement. Ultrasound Med Biol 1993; 19:567-579.
34. 34 Burns PN, Powers JE, Hope-Simpson D, Uhlendorf V, Fritzsche T. Harmonic imaging: principles and preliminary results. Clin Radiol 1996; 51 (suppl 1):50-55. This paper discusss the underlying principles of harmonic imaging and the improved signal-to-noise ratio attainable with harmonic imaging and myocardial contrast echocardiography.
35. 35 Porter TR, Xie F. Transient myocardial contrast after initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles: demonstration and potential mechanisms. Circulation 1995; 92:2391-2395.
36. 36 Apfel RE. Acoustic cavitation: a possible consequence of biomedical uses of ultrasound. Br J Cancer 1982; 45 (suppl):140-146.
37. 37 Neppiras EA, Noltingk BE. Cavitation produced by ultrasonics: theoretical conditions for the onset of cavitation [abstract]. Proc Phys Soc 1951, B64:1032.
38. 38 Wei K, Skyba DM, Firschke C, Jayaweera A, Lindner JR, Kaul S. Interactions between microbubbles and ultrasound: in vitro and in vivo observations. J Am Coll Cardiol 1997; 29:1081-1088. In this paper, the interactions between microbubbles and ultrasound in vitro and in vivo are described, and the basis of intermittent harmonic imaging is discussed.
39. 39 Wei K, Jayaweera A, Firoozan S, Linka A, Skyba D, Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998; 97:473-483. This paper describes the use of intermittent harmonic imaging in various ex vivo and in vivo settings. The technique can be used to assess average myocardial blood velocity, microvascular cross-sectional area and, therefore, myocardial blood flow.
40. 40 Carstensen EL. Acoustic cavitation and the safety of diagnostic ultrasound. Ultrasound Med Biol 1987; 13:597-606. A comprehensive review of the behavior of free gas bubbles in an acoustic field, and the mechanisms involved in stable oscillation and transient cavititation. A review of bioeffects is also included.
41. 41 Crum LA, Roy RA, Apfel RE, Holland CK, Madanshetty SI. Acoustic cavitation produced by microsecond pulses of ultrasound: a discussion of some selected results. J Acoust Soc Am 1992; 91:1113-1119.
42. 42 Child SZ, Hartman CL, McHale LE, Carstensen EL. Lung damage from exposure to pulsed ultrasound. Ultrasound Med Biol 1990; 16:817-825.
43. 43 Bailey MR, Dalecki D, Child SZ, Raeman CH, Penney DP, Blackstock DT, et al. Bioeffects of positive and negative acoustic pressures in vivo. J Acoust Soc Am 1996; 100:3941-3946.
44. 44 Brayman AA, Azadniv M, Makin IR, Miller MW, Carstensen EL, Child SZ, et al. Effect of Albunex® echo contrast agent on hemolysis of human erythrocites exposed to high-intensity pulsed ultrasound. Echocardiography 1995; 12:13-21.
45. 45 Brayman AA, Azadniv M, Cox C, Miller MW: Hemolysis of Albunex-supplemented, 40% hematocrit human erythrocites in vitro by 1 MHz pulsed ultrasound: acoustic pressure and pulse length dependance. Ultrasound Med Biol 1996; 22:927-938.
46. 46 Dalecki D, Raeman CH, Child SZ, Cox C, Francis CW, Meltzer RS, et al. Hemolysis in vivo from exposure to pulsed ultrasound. Ultrasound Med Biol 1997; 23:307-313.
47. 47 Ziskin MC. The prudent use of diagnostic ultrasound. J Ultrasound Med 1987; 6:415.
48. 48 Skyba DM, Price RJ, Linka A, Skalak T, Kaul S. Direct in vivo visualization of microbubbles destruction by ultrasound and its effects on capillaries and adjacent tissue. Circulation 1998; 98:290-293.
49. 49 Lanza GM, Wallace KD, Scott MJ, Cacheris WP, Abendschein DR, Christy DH, et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation 1996; 95: 2324-2240.
50. 50 McCreery TP, Sweitzer RH, Guanali W, Shen D, Yellowhair DW, Unger EC. Targeted ultrasound contrast agents for the detection of thrombus [abstract]. Circulation 1996; 94 (suppl 1):1-654.